Evaluation of Pilbara Antimony-Gold Potential Generates Positive Results

Go back to Evaluation of Pilbara Antimony-Gold Potential Generates Positive Results

Novo Nordisk (NVO) Shares Gain 4%, See Volume Buying Pressure

September 11, 2024 12:40 PM EDT

Novo Nordisk (NYSE: NVO) Shares Gain 4%

The move was off news from Roche which Street Insider cited saying Roche's CT-996 obesity pill had rates of nausea and GERD as high as 86% in a small study, though the side effects... More